The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study
The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study
GIANLUCA MASI, Haripriya Andanamala, Calogero Cammà, Tiziana Pressiani et al.
Citations
1 citations
Journal
The Lancet Digital Health
Topics
Hepatocellular Carcinoma Treatment and Prognosis
Field-Weighted Citation Impact (FWCI)
23.38
article
The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study
GIANLUCA MASI, Haripriya Andanamala, Calogero Cammà, Tiziana Pressiani, Pei-Chang Lee, Valentina Zanuso, FABIO PISCAGLIA, Pasquale Lombardi, Susanna Varkey Ulahannan, Noha Soror, Matthias Pinter, Mathew Vithayathil, Giulia Francesca Manfredi, Martin Schönlein, Bernardo Stefanini, Yehia I. Mohamed, Marianna Silletta, Fionnuala Crowley, Natascha Röhlen, Aria Torkpour, Wei-Fan Hsu, Antonio D’Alessio, Emanuela Di Giacomo, Ryan Po-Ting Lin, B Scheiner, Alexander Link, Mario Pirisi, Ciro Celsa, Eric Aboagye, Chun-Yen Lin, Andrea Dalbeni, Bruno Vincenzi, Michael Lapelusa, Naoshi Nishida, Linda Wu, David J Pinato, Peter R Galle, Claudia Angela Maria Fulgenzi, Giuseppe Cabibbo, Hong Jae Chon, Thomas U Marron, Lorenza Rimassa, Ahmed Kaseb, Luca Galbato, Rohini Sharma, Leonardo Natola, Celina Ang, Mariarosaria Marseglia, Arndt Vogel, Francesca Salani, Johann von Felden, Caterina Vivaldi, Alessio Cortellini, Yi-Hsiang Huang, Robert Thimme, Brooke Wietharn, Kornelius Schulze, Masatoshi Kudo, Henning Wege
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet Digital HealthVol. 8(2)
Institutions
Università Cattolica del Sacro Cuore (IT), University of Pisa (IT), University of Verona (IT), Marche Polytechnic University (IT), Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT), Mount Sinai Hospital (US), Humanitas University (IT), The University of Texas MD Anderson Cancer Center (US), Università Campus Bio-Medico (IT), Universität Hamburg (DE), University of Freiburg (DE), Scuola Superiore Sant'Anna (IT), China Medical University (TW), Johannes Gutenberg University Mainz (DE), University Medical Center Freiburg (DE), Agostino Gemelli University Polyclinic (IT), Princess Margaret Cancer Centre (CA), Taipei Veterans General Hospital (TW), University Medical Center of the Johannes Gutenberg University Mainz (DE), The University of Kansas Cancer Center (US), Mount Sinai Hospital (US), Mount Sinai Hospital (US), University Medical Center Hamburg-Eppendorf (DE), Department of Health (ES), Linkou Chang Gung Memorial Hospital (TW), Azienda USL di Bologna (IT), ASST Melegnano e della Martesana (IT), China Medical University Hospital (TW), Tisch Hospital (US), Oklahoma State University Oklahoma City (US), CHA University Bundang Medical Center (KR), Campus Bio Medico University Hospital (IT), IRCCS Humanitas Research Hospital (IT), Imperial College London (GB), University of Oklahoma Health Sciences Center (US), Medical University of Vienna (AT), University of Palermo (IT), Kindai University (JP), Icahn School of Medicine at Mount Sinai (US)